Clinical Trials
Biohaven to begin clinical development of BHV-5000 to treat...
Biohaven Pharmaceutical Holding Company Ltd. and its wholly owned subsidiary, Biohaven Pharmaceuticals, Inc., today announced that the U.S. FDA has notified the Company that it...
Clinical Trials
BioNTech Announces Results from Two More Studies Demonstrating the...
BioNTech Diagnostics GmbH is announcing new results from two studies on the MammaTyper® test which were presented at the Breast Cancer Symposium in San Antonio...
Clinical Trials
Adverum Biotechnologies Doses First Patient in the ADVANCE Phase...
Adverum Biotechnologies, Inc , a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced the dosing of the first...
Clinical Trials
GeNeuro To Receive €12 Million Milestone Payment from Servier...
GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurological and autoimmune diseases, such as multiple sclerosis (MS) and type 1...
Clinical Trials
Corbus Pharmaceuticals Initiates “RESOLVE-1” Phase 3 Study in Systemic...
Corbus Pharmaceuticals Holdings, Inc. , a clinical stage drug development company targeting rare, serious chronic inflammatory and fibrotic diseases, announced that it has initiated the...
Clinical Trials
Eisai: Updated Analysis of Phase Ib/II Study of Eribulin...
Eisai Co .Ltd. announced that a presentation on the updated analysis of a global Phase Ib/II clinical study (ENHANCE 1 / Study 218) of its...
Clinical Trials
Plasticell and Anthony Nolan to partner in clinical trials...
Plasticell, a developer of innovative stem cell technologies and cell therapies announced it will collaborate with Anthony Nolan, a leading research organisation dedicated to saving...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.